脂質タンパク質によって促進されるヒトの滑らかな筋肉細胞の増殖 (a)
D J Grainger1, H L Kirschenlohr, J C Metcalfe
1Department of Biochemistry, University of Cambridge, United Kingdom.
まとめ
増加したリポプロテイン ((a) [Lp ((a) ]とアポリポプロテイン ((a) [apo ((a) ]は,プラズミノゲンの活性化を阻害することによって,滑らかな筋肉細胞の成長を促進します. これは,動脈硬化症の発達におけるLp (a) の役割に関するメカニズムを示唆しています.
科学分野:
- 心血管生物学 心血管生物学
- 動脈硬化症の研究について
- セルラー・シグナリング
背景:
- 脂質タンパク質の上昇 (Lp) は,動脈硬化症の重要な危険因子である.
- Lp (a) とその構成要素であるアポリポプロテイン (a) [apo (a) ]の正確な生理学的機能は完全に理解されていません.
研究 の 目的:
- 滑らかな筋肉細胞の成長に関連したLp (a) とapo (a) の生理学的活動を調査する.
- Lp (a) がアテロゲネシスに寄与するメカニズムを解明する.
主な方法:
- ヒトの滑らかな筋肉細胞のインビトロ培養.
- Lp (a) と浄化されたapo (a) で処理する.
- プラズミノゲンの活性化と成長因子ベータ (TGF-β) の活性化変換を測定するアッセイ.
主要な成果:
- Lp (a) と apo (a) は,ヒトの滑らかな筋肉細胞の増殖を有意に刺激した.
- この刺激は,プラズミノゲン活性化の抑制と関連していた.
- プラズミノゲン活性化の阻害は,滑らかな筋肉細胞の成長の既知の阻害体である潜在的TGF-βの活性化を低下させた.
結論:
- Lp (a) とapo (a) は,プラズミノゲン活性化およびその後のTGF-β活性化を阻害するメカニズムを通じて,滑らかな筋肉細胞の成長を促進します.
- この発見は,Lp (a) のアテロゲン作用を説明する潜在的な分子メカニズムを提供する.
- Lp(a) 調節に関するさらなる研究は,動脈硬化症の新たな治療戦略を提供することができる.
さらに関連する動画
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
08:28Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
関連する概念動画
Inflammation
Overview
Lipid-derived Compounds in the Human Body
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
